How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?

作者信息

Bussel James B, Marks Kristen M

机构信息

Division of Pediatric Hematology Oncology, Weill Cornell Medical College, P695, 525 East 68th Street, New York, NY 10065, USA.

出版信息

Nat Clin Pract Gastroenterol Hepatol. 2008 Aug;5(8):424-5. doi: 10.1038/ncpgasthep1185. Epub 2008 Jul 8.

DOI:10.1038/ncpgasthep1185

PMID:18607406

Abstract

摘要

相似文献

How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?

Nat Clin Pract Gastroenterol Hepatol. 2008 Aug;5(8):424-5. doi: 10.1038/ncpgasthep1185. Epub 2008 Jul 8.

Treatment of chronic hepatitis C virus infection - Dutch national guidelines.

Neth J Med. 2008 Jul-Aug;66(7):311-22.

Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?

Hepatology. 2008 Apr;47(4):1418-21. doi: 10.1002/hep.22300.

Have hematopoietic growth factors made an impact on the management of liver disease?

Trop Gastroenterol. 2008 Oct-Dec;29(4):187-93.

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

J Viral Hepat. 2009 May;16(5):352-8. doi: 10.1111/j.1365-2893.2009.01080.x. Epub 2009 Feb 17.

Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias.

Semin Hematol. 2009 Jan;46(1 Suppl 2):S15-25. doi: 10.1053/j.seminhematol.2008.12.006.

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.

Haemophilia. 2009 Mar;15(2):538-43. doi: 10.1111/j.1365-2516.2009.01972.x. Epub 2009 Feb 1.

Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study.

Eur J Gastroenterol Hepatol. 2008 Sep;20(9):829-36. doi: 10.1097/MEG.0b013e3282fc73a1.

Prevention of hepatocellular carcinoma complicating chronic hepatitis C.

J Gastroenterol Hepatol. 2009 Apr;24(4):531-6. doi: 10.1111/j.1440-1746.2009.05814.x.

HCV in patients with end-stage renal disease.

Am J Gastroenterol. 2008 Aug;103(8):2123-34. doi: 10.1111/j.1572-0241.2008.01981.x.

引用本文的文献

[The efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia].

Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):32-36. doi: 10.3760/cma.j.issn.0253-2727.2018.01.007.

Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.

Exp Ther Med. 2015 Dec;10(6):2180-2186. doi: 10.3892/etm.2015.2830. Epub 2015 Oct 23.

Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.

Drug Des Devel Ther. 2010 Jul 21;4:139-45. doi: 10.2147/dddt.s8601.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验